Human and simian immunodeficiency viruses infect host lymphoid cells by binding CD4 molecules via their gp160 envelope glycoproteins. Biochemical studies on recombinant SIVmac32H (pJ5) envelope ectodomain gp140 precursor protein show that the envelope is a trimer. Using size exclusion chromatography, quantitative amino acid analysis, analytical ultracentrifugation, and CD4-based competition assay, we demonstrate that the stoichiometry of CD4 receptor-oligomeric envelope interaction is 1:1. By contrast, Fab fragments of both neutralizing and non-neutralizing monoclonal antibodies bind at a 3:1 ratio. Thus, despite displaying equivalent CD4 binding sites on each of the three gp140 protomers within an uncleaved trimer, only one site binds the ...
Human immunodeficiency virus type 1 (HIV-1) entry into target cells involves sequential binding of t...
Human immunodeficiency virus type 1 (HIV-1) entry into target cells involves sequential binding of t...
AbstractInsights into the process of HIV-1 neutralization may assist rational vaccine design. Here, ...
The human immunodeficiency virus type 1 (HIV-1) gp120 exterior envelope glycoprotein is conformation...
The trimeric envelope glycoprotein (Env) spikes displayed on the surfaces of simian immunodeficiency...
A subset of the neutralizing anti-HIV antibodies recognize epitopes on the envelope protein gp120 of...
Metastable conformations of the gp120 and gp41 envelope glycoproteins of human immunodeficiency viru...
Metastable conformations of the gp120 and gp41 envelope glycoproteins of human immunodeficiency viru...
The external domain of the envelope glycoprotein, gp120, of simian immunodeficiency virus (SIV) has ...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
Metastable conformations of the gp120 and gp41 envelope glycoproteins of human immunodeficiency viru...
The human immunodeficiency virus type 1 exterior gp120 envelope glycoprotein is highly flexible, and...
Human immunodeficiency virus type 1 (HIV-1) entry into target cells involves sequential binding of t...
Human immunodeficiency virus type 1 (HIV-1) entry into target cells involves sequential binding of t...
Human immunodeficiency virus type 1 (HIV-1) entry into target cells involves sequential binding of t...
AbstractInsights into the process of HIV-1 neutralization may assist rational vaccine design. Here, ...
The human immunodeficiency virus type 1 (HIV-1) gp120 exterior envelope glycoprotein is conformation...
The trimeric envelope glycoprotein (Env) spikes displayed on the surfaces of simian immunodeficiency...
A subset of the neutralizing anti-HIV antibodies recognize epitopes on the envelope protein gp120 of...
Metastable conformations of the gp120 and gp41 envelope glycoproteins of human immunodeficiency viru...
Metastable conformations of the gp120 and gp41 envelope glycoproteins of human immunodeficiency viru...
The external domain of the envelope glycoprotein, gp120, of simian immunodeficiency virus (SIV) has ...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
Metastable conformations of the gp120 and gp41 envelope glycoproteins of human immunodeficiency viru...
The human immunodeficiency virus type 1 exterior gp120 envelope glycoprotein is highly flexible, and...
Human immunodeficiency virus type 1 (HIV-1) entry into target cells involves sequential binding of t...
Human immunodeficiency virus type 1 (HIV-1) entry into target cells involves sequential binding of t...
Human immunodeficiency virus type 1 (HIV-1) entry into target cells involves sequential binding of t...
AbstractInsights into the process of HIV-1 neutralization may assist rational vaccine design. Here, ...